Stock sags after company announces USB power adapter recalls for iPhones.
|
The med-tech giant’s shares tick upward as defibrillator market stabilizes.
|
Boston Scientific’s CFO stands ground that buying troubled heart device maker Boston Scientific was the best thing the company ever did.
|
Year in Review: Innovation and controversy defined the medical technology industry.
|
The federal agency publishes plan that could improve post-market device safety.
|
Another notebook maker joins the recall list for Sony-made battery packs.
|
Japanese notebook maker issues count of Sony batteries it will replace.
|
ThinkPad with Sony battery installed is latest casualty in notebook power woes.
|
Medical device maker squirrels away the money to deal with the legal woes of Guidant.
|
Boston Scientific shares dip 7 percent after warnings some devices could cause problems.
|
Recent recalls stir discussion on the reporting and replacement of faulty cardiac devices.
|
Boston Scientific gets U.S. government clearance to acquire troubled heart device maker Guidant.
|
An independent panel suggests how the troubled heart device maker can better its patient safety communication skills.
|
The problem-plagued company warns doctors about possible battery troubles in some of its defibrillators.
|
Europe probes Boston-Guidant deal; Inamed’s outperforming wrinkle filler; polls shows Americans like techy medicine.
|
Inspectors say heart device maker failed to report in a timely manner on repair work for certain defibrillator products.
|
The medical device maker sets date for merger vote, then reports more problems with defibrillators.
|
Heart device maker receives a warning letter and cuts its profit outlook.
|
Medical device maker warns of potential problem in 28,000 heart devices.
|
Medical product executive sold $3.39 million in stock days before Guidant began warning of product flaws.
|
Page
1
of
2
|